HOME Research Insight Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), and Terumo BCT, Inc. (U.S) to Dominate the Global Apheresis Market

Haemonetics Corporation (U.S.), Fresenius Medical Care (Germany), and Terumo BCT, Inc. (U.S) to Dominate the Global Apheresis Market

The global apheresis market is consolidated and highly competitive, with the top five players accounting for ~ 85% of the market share in 2015. In this consolidated market, Haemonetics Corporation (U.S.), Fresenius Medical Care, and Terumo BCT, Inc. are the leading players. Other players in this market include Asahi Kasei Medical Co., Ltd. (Japan), Kawasumi Laboratories Inc. (Japan), Cerus Corporation (U.S.), B. Braun Melsungen AG (Germany), HemaCare Corporation (U.S.), Kaneka Corporation (Japan), and Nikkiso Co., Ltd. (Japan). A majority of the leading players in this market are based in developed countries across North America and Europe.

The leading position of Haemonetics Corporation is attributed to its wide product portfolio in both devices and disposables segments. The company has a wide geographic presence across the U.S., Europe, Japan, and other parts of Asia, which enables it to cater to customers across the globe. Around 50% of the company’s revenue is generated from the U.S. market. The company mainly focuses on agreements and acquisitions to maintain its position in the market.

Fresenius Medical Care is another leading company in the market. This is attributed to the company’s strong presence in North America, Europe, Asia-Pacific, Latin America, and Africa. The company is also expanding its presence in the emerging markets by strengthening its business operations in those markets. In order to increase its market share and revenue, the company pursues the strategy of product launch and acquisitions.

A majority of the top players adopted product launches; acquisitions, agreements, collaborations, and partnerships; and geographic expansions as their key growth strategies. Agreements, partnerships, and collaborations were the preferred strategy adopted by key players in the global apheresis market. For instance, in December 2016, Fresenius Kabi USA and Terumo Cardiovascular Group (U.S.) entered into a five-year distribution agreement for Fresenius Kabi’s CATSmart, a continuous autotransfusion system. This agreement allowed Fresenius Kabi to meet their customers’ need for allogeneic blood transfusions. Similarly, in October 2016, Cerus Corporation (U.S.) entered into a distribution agreement with Hemolife Fundación Banco Nacional de Sangre (Colombia) to supply Cerus’s INTERCEPT Blood System to hospitals in Colombia.

Related Reports:

Apheresis Market by Product (Plasma & Component Separator, Hemoperfusion, Disposable), Procedure (Therapeutic, Photopheresis, Donor), Application (Plasmapheresis, Plateletpheresis), Technology (Centrifuge, Membrane Separation) - Global Forecast to 2021

UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support

US : 1-888-600-6441

Search reports